Skip to content

Drug interactions

Fosaprepitant + Rimegepant

Severity: Moderate

Fosaprepitant and Rimegepant: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Fosaprepitant (aprepitant) is a moderate CYP3A4 inhibitor that can increase rimegepant exposure. The effect is typically transient after a single fosaprepitant dose but may raise adverse effect risk.

What this interaction means in plain words

Fosaprepitant and Rimegepant can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Fosaprepitant belongs to Gastrointestinal Tract; Rimegepant belongs to Central Nervous System.

Evidence level: Moderate

Why it happens

Inhibition of CYP3A4 metabolism of rimegepant by aprepitant.

What to do

For acute migraine treatment, avoid a second rimegepant dose within 48 hours of coadministration. No adjustment is needed for preventive dosing.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Fosaprepitant and Rimegepant, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Fosaprepitant with Rimegepant?

MediHelp rates the interaction as moderate. Fosaprepitant and Rimegepant can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Fosaprepitant (aprepitant) is a moderate CYP3A4 inhibitor that can increase rimegepant exposure. The effect is typically transient after a single fosaprepitant dose but may raise adverse effect risk.

How serious is the interaction between Fosaprepitant and Rimegepant?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: For acute migraine treatment, avoid a second rimegepant dose within 48 hours of coadministration. No adjustment is needed for preventive dosing.

What other medicines interact with Rimegepant?

MediHelp also lists interactions of Rimegepant with, for example, Amobarbital, Atazanavir, Butabarbital. The full list is on the Rimegepant page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in